Intelligence Platform
Patents
Browse 29,054 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 6287575
Vaccine against papillomatous digital dermatitis (PDD)
expired patentUS 6287569
Vaccines with enhanced intracellular processing
expired patentUS 6287566
Protective peptides neurotoxin of C. botulinum
expired patentUS 6287562
Methods of inhibiting the growth of cells bearing LewisY antigens using B1, B3, or B5 targ
expired patentUS 6287556
Intracellular delivery vehicles
expired patentUS 6287549
Method for removing superfluous hairs
expired patentUS 6287537
Radioimmunotherapy of lymphoma using anti-CD20 antibodies
expired patentUS 6288060
Amino substituted pyrimidines and triazines
expired patentUS 6288090
Pharmaceutical composition
expired patentUS 6284779
Heteroaromatic compounds
expired patentUS 6284536
Modified immunoglobin molecules and methods for use thereof
expired patentUS 6284491
Biologically active synthetic thyrotropin and cloned gene for producing same
expired patentUS 6284778
Methods and compositions for stimulating neurite growth
expired patentUS 6284258
Long-acting, chemical-resistant skin emollients, moisturizers, and strengtheners
expired patentUS 6284254
Immunogenic compositions comprising cold-adapted attenuated respiratory syncytial virus mu
expired patentUS 6284805
Plastics container containing stabilized drug formulation
expired patentUS 6284242
Method for enhancing myoblast migration and invasion in the context of gene therapy
expired patentUS 6280734
Simian-human HAV having a chimeric 2C protein
expired patentUS 6281381
Hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical
expired patentUS 6281256
Open pore biodegradable matrices
expired patentUS 6281196
Isolation and structural elucidation of the human cancer cell growth inhibitory compound d
expired patentUS 6280964
Binding sites for phosphotyrosine binding domains
expired patentUS 6280958
Rh blood group antigen compositions and methods of use
expired patentUS 6278040
Receptor-deficient mice and cell lines derived therefrom, and uses thereof
expired